Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
A. Lamort (München, Germany), M. Pepe (München, Germany), S. Behrend (München, Germany), I. Lilis (Rio, Greece), G. Ntaliarda (Rio, Greece), M. Spella (Rio, Greece), W. Kujawa (München, Germany), M. Lindner (Gauting, Germany), I. Koch (Gauting, Germany), R. Hatz (Gauting, Germany), J. Behr (Gauting, Germany), G. Stathopoulos (München, Germany). Molecular hallmarks of smoking in the Gauting lung adenocarcinoma donors. 1647

Member's Comments

No comment yet.

Related content which might interest you: Molecular biomarkers for lung adenocarcinoma Source: Eur Respir J , 49 (4)  1601734; DOI: 10.1183/13993003.01734-2016 Year: 2017 Molecular biologic characterization of operated non-small cell lung cancer according to smoking history Source: Annual Congress 2008 - Risk assessment and treatment of complications in thoracic surgery patients Year: 2008 Molecular and clinical profile of adenocarcinoma lung among Indian women Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up Year: 2017 Molecular imprint of lung cancer development Source: ERS Lung Science Conference 2017 Year: 2017 Molecular abnormalities and histopathology in lung cancer Source: ERS Research Seminar Year: 2015 Epidemiology of lung cancer and mesothelioma Source: Eur Respir Mon; 2009: 44: 349–391 Year: 2009 Molecular epidemiology in non small cell lung cancer (NSCLC) tumors: implication of gender and histological features Source: Eur Respir J 2006; 28: Suppl. 50, 335s Year: 2006 MUC1 associates with smoking, prognosis and histological subtypes in lung adenocarcinoma Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015 Molecular signatures of non-small cell lung cancer (NSCLC) obtained from gene expression profiling of the benign bronchial mucosa of smokers with and without NSCLC Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer Year: 2013 Molecular markers in non-small cell lung carcinoma Source: Eur Respir J 2006; 28: Suppl. 50, 86s Year: 2006 Significance of expression of TGF-β in pulmonary metastasis in non-small cell lung cancer tissues Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 Lung cancer: immunopathology Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=48 Year: 2001 Is residential radon associated with mutations in drivers genes in never smokers lung cancer cases? The case of EGFR and ALK Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer Year: 2016 RBM5 regulates EGFR involving in cancerous transformation of cigarette smoke-induced BEAS-2B cells Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Cigarette smoke alters the EZH2/DAB2IP expression in bronchial epithelial cells. A risk factor for lung cancer in COPD patients Source: International Congress 2016 – Studies in airway cell biology Year: 2016 Screening and follow up of occult lung carcinoma (Tx) in a smoker population Source: Eur Respir J 2003; 22: Suppl. 45, 249s Year: 2003 Mouse lung adenocarcinoma cell lines reveal Prl2c2 as a novel lung tumor promoter Source: International Congress 2015 – New frontiers in biomedical research on thoracic tumours Year: 2015 BioCAST/IFCT-1002: epidemiological and molecular features of lung cancer in never-smokers Source: Eur Respir J 2015; 45: 1403-1414 Year: 2015 Primary lung adenocarcinoma: characteristics by smoking habit and sex Source: Eur Respir J 2011; 38: 1412-1419 Year: 2011